The World Health Organisation stated that the Ebola outbreak in Congo represents a “high risk” for the country.
In a press conference in Geneva, Peter Salama who is the director for health emergencies programme of WHO stated: “As of now we don’t know the full extent of the outbreak.”
Based on reports, there are two confirmed cases, at least 18 others are suspected and three people have died in north-eastern Bas-Uele province.
The campaign against the virus is expected to cost 10 million dollars over the next six months, according to WHO.
The priority to is to find more than 400 people who were in contact with the confirmed or suspected Ebola sufferers, Salama said.
An Ebola treatment centre has been set up in the region and a mobile clinic is due to follow.
Since the discovery of the virus in 1976, the Central African country has suffered seven previous outbreaks of Ebola. The last outbreak was in 2014 where there are 49 people have died.
The haemorrhagic fever has been most detrimental in West Africa, where it claimed more than 11,000 lives in 2014-15.
Based on reports from WHO, the three countries including Guinea, Liberia and Sierra Leone, were greatly affected by the epidemic, and free of Ebola in 2016.
And on May 12, WHO said that the GAVI global vaccine alliance has some 300,000 emergency doses of an Ebola vaccine developed by Merck and could be available in case of a large-scale outbreak. The vaccine, known as “rVSV-ZEBOV”, was shown to be highly protective against Ebola in clinical trials published in December 2016.
According to the spokesperson of WHO, a person died in the Democratic Republic of Congo on Friday due to the virus.